Hepatotoxicity case due to interferon beta-1a use

[ X ]

Tarih

2023

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Interferon ?-1a is an immunomodulatory drug widely used in the treatment of multiple sclerosis. Liver dysfunction is a common side effect of this drug and usually develops within the first 6 months of starting interferon therapy. Here, we present our case who developed hepatotoxicity secondary to interferon ?-1a treatment.

Açıklama

Anahtar Kelimeler

Kaynak

Akademik Gastroenteroloji Dergisi

WoS Q Değeri

Scopus Q Değeri

Cilt

22

Sayı

3

Künye